{"name":"Volastra Therapeutics, Inc.","slug":"volastra-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Sovilnesib","genericName":"Sovilnesib","slug":"sovilnesib","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Sovilnesib","genericName":"Sovilnesib","slug":"sovilnesib","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxPMUN1S1RaY0g2RWhKUkJQTEh1MERVV3k1aDNMeVBTYmVxcVp4dlpGQ3JmRVZoYnlNTzZhOFA5RDhkc19ld0FPSjU5NE10UkNKT3ZiZnVYWGY1ZDU1QjI4UzZHTWlFV2pRV193dURWY2c4MXRoQXk0RmwwYTZIV25mM1hZd283bUZEeGdfZmQ2NkdxQjhYc2FMT0RiWXJHR1RSVkMwdkJYQVhiYXR0MXZESDFuMkVueWx1dENxN09WR2Vfa01UaG5fajQ1S2ZkWWZGM2lkRk1SY3pPNjFxRk42QWtxLWlYdEo1WDlhcG5XV0MxYWlSR0Q2RGtEdndkaFo2MzVmdm9hRlExVDZ5cmRvSmdIUXBaS0xidGJ3aW1HSVBBUFRVZURGeW5PSW1UbENyQmYwZHJrUEVQRnNxQ0RqbjJMUGhZNVk?oc=5","date":"2026-01-07","type":"trial","source":"businesswire.com","summary":"Volastra Therapeutics Expands Clinical Development Program Following Encouraging KIF18A Inhibitor Data and Appoints New Chief Medical Officer to Lead Clinical Strategy - businesswire.com","headline":"Volastra Therapeutics Expands Clinical Development Program Following Encouraging KIF18A Inhibitor Data and Appoints New ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNMldJM0FhMThaMlR2RHZmV0kxejlRUWViMHNsd3hRS1JFOHB1cW54VTJRZ2pCZGJoSGtSMVllR2J1d2g2VzctSlUxQnRnZ0pZckVJT3dXc1MwUmZpU0U0U0xxWGlIVTFPbUJIR0U0Q3NVUy05c19BVFM0bXlYdF9Gbnp6akdLMEJaLW5YcDFKTGh0MExH?oc=5","date":"2025-05-30","type":"pipeline","source":"Fierce Biotech","summary":"20-year Novo vet lands first CEO role—Chutes & Ladders - Fierce Biotech","headline":"20-year Novo vet lands first CEO role—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOMGFYMl9TXzZrMDdOd3dCaDk4bEZLeEZnTWVyVVhibVdZSVJESGM2WDh4SWdfWWNFb29udERqSzBkdnNteC1lZmpKRXd4Y1VwZVJ3d2xmQ0pKWmhUX0hKU1U4WDVQSXJTRmlDYnI4NDliQVNzbFh6cjVKcnhhSFhvaGIzc1ZYdXBxWFdyV2ZPbHpyaEF3?oc=5","date":"2025-05-28","type":"pipeline","source":"BioCentury","summary":"Southwell succeeds Hugh-Jones as CEO of Volastra - BioCentury","headline":"Southwell succeeds Hugh-Jones as CEO of Volastra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQRGtjQ0JSQ2ctbUV3S2oyMW50bnQtbEJVSGxTellmS2swa2M0bVcxZFBaZEIxTEhTclNqSDF2ZUFUUVlXakMwUF9oTlhNeGEwWEFhenhBSWpaVWhKa0hnZ2tia253R21EUTdRVUlQZHhkUGQwdzNYSkxYTFE5aGFuSVZKY0t4eUlMX1E4OUx2dFpMdm9Zem1lZDViMA?oc=5","date":"2025-05-27","type":"pipeline","source":"Yahoo Finance","summary":"Volastra Therapeutics Announces Appointment of David P. Southwell as Chief Executive Officer - Yahoo Finance","headline":"Volastra Therapeutics Announces Appointment of David P. Southwell as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNYlQxMmZLZHd6eHBzejNlTVBSM0xONk5qQjZCREg5Zkt1WnBQVzNZUXUyVm9TLWpOZzlBb2pfSXRnT2p2aGFWZ0ZTc1VLMjF6TVBWc0FRZnpzWDdEM2hTWnUyU3p3aEduLVd3UVoyRGJHNWdNLWhOVnV4MjZnQ2s4SlVKWGtqUUUzNnJIeU82NEtOalh2MVRMdThTZG5nRkE?oc=5","date":"2024-11-01","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in October 2024 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in October 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQQ0ZTYl9LMGg1cWhCdGIybFNwcWxYS2hxbkdvWWdnZGZGVkhRZXpyMEFaRndHY0V1RVNJS2Y3YldiLVdmanc1cy1ialBPUXFCWVRoLU9QN2UyVnlUeVR3ZjdkSndoU2w4aFJfX1hMbERZX0pkemw4Qjl3TkFSM1pGQkZTYzdSdmxtUmNoc0dPbnBFT3BxdUlWRGRLNzNicHZlN1RBN0tqLU5IcW5NNk5BUEtraTR0aWs1Z3hVTzBidFlCck5NTFlPZmpYT1p4RlRxckVyaTMySUpwUmFjbm5JOUZ6RklKbGhfa0NyT1JIYw?oc=5","date":"2024-10-02","type":"regulatory","source":"businesswire.com","summary":"Volastra Therapeutics Granted FDA Fast Track Designation for Novel KIF18A Inhibitor in Ovarian Cancer - businesswire.com","headline":"Volastra Therapeutics Granted FDA Fast Track Designation for Novel KIF18A Inhibitor in Ovarian Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPSmc4d0RXZTJKRmlfWjQ0MGcyMmJ3LTh3cTJpdmprZ19UWk1CUWJBWTF1VDV0djgwSm1lVUVWQ0tBZkFLeEtmSjJla29iYXdGVVpwbEFiS01ETzdHajl0NzlNMjlUdXZSbE5SZ3ZBNm0waTkxdG96OXF1aTJjMDFXMjBEakJhYkNGcDRQSk9nZ1VZYmxkcmc?oc=5","date":"2024-04-19","type":"trial","source":"Oncology Pipeline","summary":"Volastra vies for the next big synthetic lethality target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Volastra vies for the next big synthetic lethality target | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNOER4OXhfM0liXzlNVmJ4MnRGaGpnT3ZuOU04dnctRWZoS295dkNpRHdFdnJXbVltUjNEcExDZ0d3TEVQdkZ0NzZocFg2NG9wQ1NLWlhXM3pYZXFJUHJpWUtQdzFPNnNFa3ZocV94MENzd0FmcUlSSVByN2FaMUwxX2otTDRlcGNTZUVIYjNERmhOVTNnNDJlNzJQZmkySXJrOFRod25vWmthRVduNDNhdU4wUEpaTmZSeE1SZmtYaUl6OHIxNGhRXzR3Qjd4WGF3QmEwd1JpVnU1Uy1Vc05nWTNrSQ?oc=5","date":"2024-04-16","type":"trial","source":"businesswire.com","summary":"Volastra Therapeutics Announces First Patient Dosed in Phase Ib Clinical Trial of Sovilnesib - businesswire.com","headline":"Volastra Therapeutics Announces First Patient Dosed in Phase Ib Clinical Trial of Sovilnesib","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPZUlKN3M3Vzl1WUptcldSMi16WHRCUGo3bFFGSlYyTE1wLVhnallJdndOSkhIcnQ1YkJLUXhMbnhPa045MFVoSFVDTjdJRVhzX2hkSy1TdlFHajlsR29ZR3AxSmNlNENHSnNtLTNDUnlVcTFxMldwU1UwM25BNVJaQ0x1X2xfSTFsS2lSbzVIaGZMQ1h2R3VHRXFBaWEzYk9WTUdQb3F5RW5uNms?oc=5","date":"2023-03-07","type":"deal","source":"cen.acs.org","summary":"Volastra licenses Amgen molecule for chromosomally unstable cancers - cen.acs.org","headline":"Volastra licenses Amgen molecule for chromosomally unstable cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNMHdyOGtveEhSb2VDVmF6ZXcyM3UwSUo0dU8zaG5aZjBJd0tDbFRjSktwdEFhc3cyMWE5amxTQVdZd1hGM0k1SF9NZHl1cy1XV2FTN2V4bHVRdFhHQ2tpdWtEZXZOakNVaVFwS0JwNHNrV3A5ckY0b2xfYnpyb0phc3hPQjBtZHNYM1BESHE0ZmNwenNEZWVBalJ4a0FLNUlxcWJzU1hpWjBuQWN4czktWHk5QUZjaTF5TldwQzB6ZmxDbWN4WGc?oc=5","date":"2023-03-07","type":"pipeline","source":"Fierce Biotech","summary":"Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med - Fierce Biotech","headline":"Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQbUVCUk5hcTU4cVk2ZWlFbHl6MjY2b1I2dWllcThsd0JKaFQ4aThjWGtEWml5V0NqOFhZLWRZbGcyU09URWpkRXZNLUluZE9CNlF6MXRHNjBGUlJQN0VNMGhQblZsS2FRMTNDaVB0Yl90b2xVRW1DNGtXdGVicVB0SDJBU2lmQVU4OUVFZjdKV2RnaDY3YVNvRE1kM1hkeE8yWGF6anhkMA?oc=5","date":"2022-03-22","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Cardinal CIN: Volastra, BMS Commence Up-to-$1.13B Cancer Collaboration - Genetic Engineering and Biotechnology News","headline":"Cardinal CIN: Volastra, BMS Commence Up-to-$1.13B Cancer Collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxObFhsN0tUT2JjQUpQYjVQUE1sRXIyVVIxRWlaYlJWQ3d6dDRSY1JyM3RneTh5dWh5YmIzMjF5SkpDOVZZSDVvb2E3UmpyYUNtWHBiSGJVaGVMV0Ewd1gtOEkxQ2ZPd2FTMDdtMUJBN0tpd3cySFRaY3VZa1ZydGhyQnVidTJ1UXhxMHQya05CcTZDdHBw?oc=5","date":"2022-03-21","type":"deal","source":"pharmaphorum","summary":"BMS buys into Volastra's cancer expertise with $1.1bn alliance - pharmaphorum","headline":"BMS buys into Volastra's cancer expertise with $1.1bn alliance","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}